Arbesideas Inc is categorized under Research and Development Laboratories in Buffalo, NY and active since 2002.
Arbesideas Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Marian Arbesman at the company’s single location by writing to 7954 Transit Road 307, Buffalo, New York NY 14221 or by phoning (716) 517-6383. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Arbesideas Inc |
| Contact Person: | Marian Arbesman |
| Address: | 7954 Transit Road 307, Buffalo, New York 14221 |
| Phone Number: | (716) 517-6383 |
| Website Address: | arbesideas.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Arbesideas Inc was started in 2002 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Marian Arbesman for inquiries that concern Arbesideas Inc by calling the company number (716) 517-6383, as your correspondence is most welcome. Additionally, the physical location of the single location of Arbesideas Inc can be found at the coordinates 42.979444,-78.739343 as well as the street address 7954 Transit Road 307 in Buffalo, New York 14221.
For its online presence, you may visit Arbesideas Inc’s website at arbesideas.com and engage with its social media outlets through on Twitter and on Facebook.